Vizient has ranked Rush University Medical Center #1 for quality among the nation’s most prestigious academic medical centers. Learn more.
ARAMIS Registry: Addressing Anticoagulant Management Issues in Stroke
The ARAMIS Registry is a multicenter, prospective, observational study of acute ischemic stroke (AIS) and intracerebral hemorrhage (ICH) patients on home anticoagulation therapy.
In order to participate you must meet the following criteria:
- Be 18 years of age or older.
- Are diagnosed with AIS and on dabigatran, rivaroxaban, apixaban or edoxaban prior to admission.
- Are diagnosed with ICH and on warfarin or one of the new oral anticoagulats prior to admission.
You will be excluded from the study if any of the following criteria apply to you:
- Were transferred from another hospital or discharged to another acute care facility.
This is a partial list of inclusion and exclusion criteria.